Lab study looks at how losing a key gene may help brain tumors start
Original title: p53 knockout drives stage-specific long non-coding RNA reprogramming during human neural differentiation and glioma organoid tumorigenesis.
How far along is this research?
This is a preprint. Other scientists have not checked it yet, so treat it as an early signal rather than an answer.
This was only done with cells grown in a lab.
The short version
Scientists grew brain-like cells in the lab to learn how a brain tumor might first begin.
What was studied. Researchers used human stem cells with a gene called TP53: A gene checked on the tumor tissue. Whether it has changed is one of the findings used to name an astrocytoma. Ask your team whether the change they found was in the tumor only. See the glossary turned off. p53 normally helps stop cells from turning into cancer. They grew these cells into early brain cells and tiny lab-grown brain models. Then they compared them to glioblastoma: A glioma that is given grade 4, the highest grade. It grows fast. Treatment usually starts soon after it is found. It often means surgery, then radiation and chemotherapy. See the glossary cells grown in the lab.
What they found. Without TP53: A gene checked on the tumor tissue. Whether it has changed is one of the findings used to name an astrocytoma. Ask your team whether the change they found was in the tumor only. See the glossary, the cells changed which helper molecules they made, and the changes built up over time. The biggest change was seen in cells grown for 40 days. At that point, the cells looked partly like glioblastoma: A glioma that is given grade 4, the highest grade. It grows fast. Treatment usually starts soon after it is found. It often means surgery, then radiation and chemotherapy. See the glossary cells. Five of these helper molecules were higher in both the gene-changed cells and the tumor cells. Two of them had not been linked to this kind of tumor before.
What this means, and what it doesn't
What it could mean: This may help scientists understand how some brain tumors first get started. The molecules they found could someday be studied as signs of a tumor or as targets for new treatments.
What it doesn't mean: This was done only with cells in a lab dish. It was not tested in animals or people. It does not give patients a new test or treatment. Any use in care is many years away, if it happens at all. It is not a cure.
Source: bioRxiv (preprint), September 18, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.